Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: INCY stock price vs SPGI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SPGI's multiple
Needs SPGI P/E.
Implied fair value · at INCY's multiple
Needs INCY P/E.
Live quote
Price unavailable
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Profitability edge
Asset efficiency edge
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: INCY FY 2025 (ended Dec 31, 2025) · SPGI FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
—
Tangible equity
$4.80B
Price / tangible book
—
Price / book
—
Return on equity
24.9%
Return on assets
18.5%
Efficiency ratio
—
Price / book
Market cap
—
Tangible equity
-$21.62B
Price / tangible book
—
Price / book
—
Return on equity
14.4%
Return on assets
7.3%
Efficiency ratio
—
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
INCYTE CORPORATION · implied price per share
Bear
-$7.58
Base
-$8.91
Bull
-$10.25
S&P Global Inc. · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
3.83x
0.44x
Net debt / EBITDA
Leverage against operating earnings
9.31x
1.54x
Cash and equivalents
Liquid reserves on the balance sheet
$3.38B
$1.80B
Total debt
Interest-bearing obligations outstanding
$19.78B
$13.81B
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
INCY vs AMGN
GILEAD SCIENCES, INC.
INCY vs GILD
VERTEX PHARMACEUTICALS INC / MA
INCY vs VRTX
REGENERON PHARMACEUTICALS, INC.
INCY vs REGN
BIOGEN INC.
INCY vs BIIB
Moody's Corporation
INCY vs MCO
MSCI Inc.
INCY vs MSCI
Verisk Analytics, Inc.
INCY vs VRSK
Intercontinental Exchange, Inc.
INCY vs ICE
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
